The current drug discovery paradigm in the West is constrained in what it can do, primarily due to the funding model. Here we envisage a hypothetical non-governmental, non-profit organization called the Centre for Affordable Medicine. By sourcing innovation from a network of academic and corporate partners, and working primarily in India, it could lower the cost of innovation. Funding could be from a variety of players that expect a social, not financial, return. The drugs thus developed could be licensed out to a limited number of generic pharma companies, and thus be available at generic prices immediately.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/bio-business-brief-case-new-drugs-generic-prices-india
[2] http://admin.indiaenvironmentportal.org.in/category/author/suri-venkatachalam
[3] http://admin.indiaenvironmentportal.org.in/category/author/gayatri-saberwal
[4] http://admin.indiaenvironmentportal.org.in/category/journal/current-science
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/finance
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/aid
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/aid-agencies
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/unicef
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/who
[13] http://admin.indiaenvironmentportal.org.in/category/thesaurus/oman
[14] http://admin.indiaenvironmentportal.org.in/category/thesaurus/private-sector
[15] http://admin.indiaenvironmentportal.org.in/category/thesaurus/council-scientific-and-industrial-research-csir
[16] http://admin.indiaenvironmentportal.org.in/category/thesaurus/international-cooperation
